Pages that link to "Q77196752"
Jump to navigation
Jump to search
The following pages link to EFFECT OF ANTIDEPRESSIVES AND GENETIC FACTORS (Q77196752):
Displaying 13 items.
- Differentiation of two genetically specific types of depression by the response to antidepressant drugs (Q34635038) (← links)
- THE PHARMACOTHERAPY OF THE DEPRESSIVE SYNDROME (Q35496240) (← links)
- Clinical significance of plasma imipramine levels (Q35665748) (← links)
- A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression (Q35737324) (← links)
- Pharmacogenetics of antidepressant response: an update (Q37464458) (← links)
- Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options (Q37612442) (← links)
- Risk-benefit assessment of newer versus older monoamine oxidase (MAO) inhibitors (Q40665054) (← links)
- Antidepressants and tranquillizers: biochemical aspects (Q46148603) (← links)
- Monoamine oxidase and inhibitors (Q48946595) (← links)
- Brain amine concentrations after monoamine oxidase inhibitor administration (Q51109844) (← links)
- The effect of imipramine administered before and during pregnancy on litter size in the rat (Q69622469) (← links)
- Differentiation of two genetically specific types of depression by the response to antidepressant drugs (Q71523302) (← links)
- Imipramine metabolism in man. A study of urinary metabolites after administration of radioactive imipramine (Q72301200) (← links)